NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q]
NDA201739
RxCUI: 1305268
What the CMS Formulary Data Shows for NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q]
Per the CMS 2026 Part D formulary file, NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] (RxNorm concept RXCUI 1305268, generic name NDA201739) appears on 11 distinct formulary files spanning 983 Medicare Part D plan offerings - 19.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 3, with a cross-plan average of Tier 2.8.
Real-world access to NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 63.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 782 Part D beneficiaries filled NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] in 2023, with total plan-and-beneficiary spending of $719,315 and an average per-beneficiary annual cost of $919.84. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] today.
Coverage Details
- Formularies covering
- 11
- Plans covering
- 983
- Coverage rate
- 19.4%
- Tier range
- Tier 2 – Tier 3
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 63.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 782
- Total spending
- $719,315
- Avg per beneficiary
- $919.84
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] covered by Medicare Part D?
Yes, NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] is covered by 983 Medicare Part D plans (19.4% of all Part D formularies).
What tier is NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] on Medicare Part D plans?
NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] averages Tier 2.8 across Part D plans, ranging from Tier 2 to Tier 3.
Does NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] require prior authorization?
0% of Part D formularies require prior authorization for NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q]. Step therapy: 0%. Quantity limits: 63.6%.
How much does Medicare spend on NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q]?
In 2023, total Medicare Part D spending on NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector [Auvi-Q] was $719,315, covering 782 beneficiaries. The average spend per beneficiary was $919.84.
Read our methodology - how this data is sourced, computed, and verified.